Aripiprazole for relapse prevention and craving in alcohol-dependent subjects: Results from a pilot study [5]

Journal of Clinical Psychopharmacology

Volumn 27, Issue 5, 2007, Pages 519-520

  Janiri, Luigi ^a   Martinotti, Giovanni ^a   Di Nicola, Marco ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; DEXAMPHETAMINE;

ADDICTION; ALCOHOLISM; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG EFFICACY; DRUG WITHDRAWAL; HUMAN; LETTER; NAUSEA; PRIORITY JOURNAL; RELAPSE; VOMITING; WITHDRAWAL SYNDROME;

ADULT; ALCOHOL DETERRENTS; ALCOHOL DRINKING; ALCOHOLISM; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ADDICTIVE; DIAGNOSIS, DUAL (PSYCHIATRY); DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PILOT PROJECTS; PIPERAZINES; QUINOLONES; RECURRENCE; TEMPERANCE;

EID: 34548696853     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318150c841     Document Type: Letter

References (13)

1. Carlsson C, Gullberg B. A double blind study with melperone and placebo in the treatment of chronic alcoholics. Int J Clin Pharmacol Biopharm. 1978;16(7):331-332.
2. Shaw GK, Majumdar SK, Waller S, et al. Tiapride in the long-term management of alcoholics of anxious or depressive temperament. Br J Psychiatry. 1987;150:164-168.
3. Naranjo CA, Dongier M, Bremner KE. Long-acting injectable bromocriptine does not reduce relapse in alcoholics. Addiction. 1997;92(8):969-978.
4. Rosenbaum JF, Fredman SJ. Pramipexole treatment for cocaine cravings. Am J Psychiatry. 1999;156(11):1834.
5. 2 antagonists increase relapse rates in animal studies and in clinical trials. J Biomed Sci. 2001;8(1):83-88.
6. Beresford TP, Clapp L, Martin B, et al. Aripiprazole in schizophrenia with cocaine dependence: a pilot study. J Clin Psychopharmacol. 2005;25(4):363-366.
7. Warsi M, Sattar SP, Bhatia SC, et al. Aripiprazole reduces alcohol use. Can J Psychiatry. 2005;50(4):244.
8. Stahl SM. Dopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of action. J Clin Psychiatry. 2001;62(12): 923-924.
9. Stoops WW, Lile JA, Glaser PE, et al. A low dose of aripiprazole attenuates the subject-rated effects of D-amphetamine. Drug Alcohol Depend. 2006;84(2):206-209.
10. Ingman K, Kupila J, Hyytia P, et al. Effects of aripiprazole on alcohol intake in an animal model of high-alcohol drinking. Alcohol Alcohol. 2006;41(4):391-398.
11. Lejoyeux M, Solomon J, Ades J. Benzodiazepine treatment for alcohol-dependent patients. Alcohol Alcohol. 1998;33(6):563-575.
12. Janiri L, Calvosa F, Dario T, et al. The Italian version of the Obsessive-Compulsive Drinking Scale: validation, comparison with the other versions, and difference between type 1- and type 2-like alcoholics. Drug Alcohol Depend. 2004;74(2):187-195.
13. Verheul R, van den Brink W, Geerlings P. A three-pathway psychobiological model of craving for alcohol. Alcohol Alcohol. 1999; 34(2):197-222.